TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors - PubMed (original) (raw)

. 1997 Jul 1;159(1):117-25.

Affiliations

PMID: 9200446

TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors

J Tang et al. J Immunol. 1997.

Abstract

Development of lymphoid progenitors in vivo requires interaction with a bone marrow stromal microenvironment containing multiple cytokines involved in the development of nonlymphoid hemopoietic lineages. We tested the effect of one such cytokine, TGF-beta, on the proliferation of early human clonogenic lymphoid progenitors using a stroma-dependent in vitro culture system. TGF-beta caused a dose-dependent inhibition of lymphoid progenitor colonies that was reversible at low TGF-beta doses by addition of exogenous IL-7 to the cultures. IL-7 was unable to reverse the inhibitory effect of higher TGF-beta concentrations or inhibition caused by IL-1alpha, IL-4, or TNF-alpha. Stromal IL-7 mRNA expression and protein secretion were markedly down-regulated by TGF-beta, suggesting that inhibition of stromal IL-7 secretion partially accounts for the inhibitory effect of TGF-beta on lymphopoiesis in this culture system. It is likely that higher TGF-beta concentrations do not inhibit lymphopoiesis by down-regulating IL-7 receptor expression, since this cytokine did not reduce IL-7R alpha or gamma c mRNA levels in normal B cell precursors. Since direct stromal contact is required for in vitro lymphopoiesis, the potential regulation of the IL-7 pathway by cell adhesion was examined. Adhesion of human B cell precursors to stroma did not alter stromal IL-7 expression or expression of IL-7R alpha or gamma c-chains by B cell precursors. These results indicate that TGF-beta is a significant negative regulator of stroma-dependent proliferation of early human lymphoid progenitors and acts in part by down-regulating stromal IL-7 secretion.

PubMed Disclaimer

Cited by

Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered.
Losada-García A, Cortés-Ramírez SA, Cruz-Burgos M, Morales-Pacheco M, Cruz-Hernández CD, Gonzalez-Covarrubias V, Perez-Plascencia C, Cerbón MA, Rodríguez-Dorantes M. Losada-García A, et al. Front Genet. 2022 Jan 17;12:673180. doi: 10.3389/fgene.2021.673180. eCollection 2021. Front Genet. 2022. PMID: 35111194 Free PMC article. Review.
Cellular senescence in lymphoid organs and immunosenescence.
Budamagunta V, Foster TC, Zhou D. Budamagunta V, et al. Aging (Albany NY). 2021 Aug 12;13(15):19920-19941. doi: 10.18632/aging.203405. Epub 2021 Aug 12. Aging (Albany NY). 2021. PMID: 34382946 Free PMC article. Review.
Interleukin (IL)-7 Signaling in the Tumor Microenvironment.
Bednarz-Misa I, Bromke MA, Krzystek-Korpacka M. Bednarz-Misa I, et al. Adv Exp Med Biol. 2021;1290:9-49. doi: 10.1007/978-3-030-55617-4_2. Adv Exp Med Biol. 2021. PMID: 33559853
Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity.
Xue VW, Chung JY, Córdoba CAG, Cheung AH, Kang W, Lam EW, Leung KT, To KF, Lan HY, Tang PM. Xue VW, et al. Cancers (Basel). 2020 Oct 23;12(11):3099. doi: 10.3390/cancers12113099. Cancers (Basel). 2020. PMID: 33114183 Free PMC article. Review.
Racial Differences in Immunological Landscape Modifiers Contributing to Disparity in Prostate Cancer.
King Thomas J, Mir H, Kapur N, Singh S. King Thomas J, et al. Cancers (Basel). 2019 Nov 25;11(12):1857. doi: 10.3390/cancers11121857. Cancers (Basel). 2019. PMID: 31769418 Free PMC article. Review.

TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors - PubMed (original) (raw)